Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Tortoise

Penn Capital Special Situations Small Cap Equity Fund Institutional Class (PSCNX)

Ticker PSCNX · Since 2015-12-17 · · Holdings as of May 31, 2026

Expense ratio
1.09%$109/yr per $10k
5-yr return
+11.5%annualized
1-yr return
+8.0%as of Dec 2024
Net assets
$108.2Mall share classes
Holdings
84

Bottom line

Is PSCNX a good fund? The bottom line

PSCNX is the Institutional Class share class of Penn Capital Special Situations Small Cap Equity Fund, an actively managed small-cap mutual fund from Tortoise.

Annual fees run 1.09% — about $109 a year on every $10,000 invested, more expensive than 59% of small-cap funds we track.

It returned +8.0% over one year, +11.5% a year over five years (as of Dec 31, 2024, per its prospectus).

With $108 million in net assets and 84 holdings, its largest position is Ouster Inc (2.6%) and the top 10 make up 20.2% of the portfolio.

What stands out

  • 5-year return beat 93% of category peers
  • No front-end sales load

Updated Nov 19, 2026

What PSCNX invests in

The Penn Capital Special Situations Small Cap Equity Fund (the ?Fund?) seeks to provide capital appreciation.

The Fund seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets in the equity securities of small-capitalization companies. Small-capitalization companies are defined for this purpose as companies with market capitalizations at the time of purchase between the lesser of $100 million or the market capitalization of the smallest company included in the Bloomberg US 2000 Index and the greater of $6 billion or the market capitalization of the largest company included in the Bloomberg US 2000 Index. As of October 31, 2025, the minimum and maximum market capitalizations included in the Bloomberg US 2000 Index were approximately $20 million and $14.4 billion, respectively. The Fund is not required to sell equity securities whose market values appreciate or depreciate outside this market capitalization range. In selecting investments…

From the fund's prospectus (filed Jan 5, 2026).

PSCNX performance

Fund calendar-year total returns, 2016–2024 2016: +20.6%; 2017: +15.9%; 2018: −16.2%; 2019: +29.0%; 2020: +27.6%; 2021: +33.3%; 2022: −18.0%; 2023: +14.4%; 2024: +8.0% +21% 2016 +16% 2017 −16% 2018 +29% 2019 +28% 2020 +33% 2021 −18% 2022 +14% 2023 +8% 2024
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
PSCNX+8.0%+11.5%—
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2024

Full PSCNX performance history →

What PSCNX costs

On a $10,000 investment, PSCNX's 1.09% expense ratio costs about $109 a year. The prospectus estimates $2,008 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full PSCNX fee table →

PSCNX top 10 holdings

#Holding% of fund
1Ouster Inc OUST2.64%
2ACM Research Inc ACMR2.50%
3Mirum Pharmaceuticals Inc MIRM2.13%
4US Bank Mmda - Usbfs 22.00%
5RXO Inc RXO1.98%
6Constellium SE CSTM1.85%
7Lumen Technologies Inc LUMN1.84%
8Legence Corp LGN1.83%
9Wolfspeed Inc WOLF1.73%
10Ligand Pharmaceuticals Inc LGND1.70%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 20.2% of the fund. See all top 25 holdings and asset mix →

Alternatives to PSCNX

More funds like PSCNX →

PSCNX FAQ

What is the expense ratio of PSCNX?
PSCNX's expense ratio is 1.09%, which works out to about $109 a year for every $10,000 invested. The prospectus estimates total costs of $2,008 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is PSCNX a good investment?
It depends on your goals, but the data points to: 5-year return beat 93% of category peers; no front-end sales load. This is general information, not personalized advice.
What does PSCNX hold?
PSCNX's largest holdings are Ouster Inc (2.6%), ACM Research Inc (2.5%), Mirum Pharmaceuticals Inc (2.1%), US Bank Mmda - Usbfs 2 (2.0%), RXO Inc (2.0%). It holds 84 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is PSCNX's 5-year return?
PSCNX returned +11.5% a year over the five years ending Dec 31, 2024. Past performance does not guarantee future results.
Does PSCNX have a sales load?
No. PSCNX has no front-end sales charge.
Who manages PSCNX?
PSCNX is offered by Tortoise through RBB Fund Trust.